North America Fat Reduction Market – Industry Trends and Forecast to 2033

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Fat Reduction Market – Industry Trends and Forecast to 2033

  • Medical Devices
  • Published Report
  • Sep 2023
  • North America
  • 350 Pages
  • No of Tables: 530
  • No of Figures: 44

North America Fat Reduction Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
2024 –2033
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD 11,773.56
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

North America Fat Reduction Market, By Type (Surgical Fat Reduction, Non-Invasive Fat Reduction, and Minimally Invasive), Application (Abdominal Fat, Thighs Fat, Buttock Fat, Upper-Arm Fat, Facial Fat-Deposits, and Knee Fat), Gender (Female and Male), Age Group (Adult, Geriatric, and Child), End User (Hospitals, Multi-Specialty Clinics, Dermatology Centers, Medical Spas and Beauty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors and Others), Industry Trends and Forecast to 2033.

North America Fat Reduction Market

North America Fat Reduction Market Analysis and Insights

The North America fat reduction market is expected to grow in the forecast period due to the increasing demand for minimally invasive and non-invasive procedures and decreased disparity between men and women for aesthetic functions. The market is also influenced by the growing aesthetic consciousness and beauty standards and growing technological advancement. However, the North America fat reduction market is expected to be hampered by the high cost of procedures, increased risks associated with the procedures, and product recall.

North America Fat Reduction MarketNorth America Fat Reduction Market

The customized treatment plans and integration with other aesthetic procedures, beliefs, and trends of fat reduction in young adults and focus on inclusivity and diversity and expansion of product lines are expected to act as opportunities for market growth. However, low term efficacy and sustainability and longer recovery time of the procedure is expected to challenge market growth.

The demand for the fat reduction market has increased in both developed and developing countries, and the reason behind this is its effectiveness and availability. Thus, many market players offer fat reduction products with innovations that pave the way for the growth of the North America fat reduction market.

Data Bridge Market Research analyzes that the North America fat reduction market is expected to reach the value of USD 11,773.56 million by 2033, at a CAGR of 9.9% during the forecast period.

Report Metric

Details

Forecast Period

2023 to 2033

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million

Segments Covered

Type (Surgical Fat Reduction, Non-Invasive Fat Reduction, and Minimally Invasive), Application (Abdominal Fat, Thighs Fat, Buttock Fat, Upper-Arm Fat, Facial Fat-Deposits, and Knee Fat), Gender (Female and Male), Age Group (Adult, Geriatric, and Child), End User (Hospitals, Multi-Specialty Clinics, Dermatology Centers, Medical Spas and Beauty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors and Others)

Countries Covered

U.S., Canada, Mexico, Costa Rica, Dominican Republic, Panama, El Salvador, Guatemala, Honduras, and Nicaragua

Market Players Covered

Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical (Subsidiary of Bausch & Lomb Incorporated), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona, and Implantech., among others.

North America Fat Reduction Market Definition

Fat reduction refers to reducing the amount of body fat or adipose tissue in an individual's body. It involves strategies and techniques aimed at promoting weight loss and decreasing the overall percentage of body fat. Body fat reduction can be done through surgical and non-surgical procedures. Various treatments are available such as laser lipolysis, cry lipolysis, liposuction, injectable treatment, and others.

North America Fat Reduction Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

  • Increasing Demand for Minimally Invasive and Non-Invasive Procedures

The use of minimally invasive and non–invasive procedures has been shifted as compared to traditional methods for fat reduction techniques including laser and other energy-based devices. For the use of surgical or non-surgical procedures specially designed instruments have been developed for the minimally used procedures.

Minimally invasive surgery is a procedure conducted with the assistance of a scope of viewing and specially equipped surgical instruments. Using minimally invasive procedures allows no cuts or minimal cuts with lesser recovery time allowing the increasing demand and use of minimally invasive procedures. Other reasons for the rise of procedures can be defined by the increasing aging people and the requirement for healthcare facilities including patient-friendly techniques whose medical requirements are maximum which can further result in a decreased burden on healthcare facilities.

The minimally invasive/non-invasive procedures are in line with the patient's comfort. They almost do not have any side effects and their time of recovery is too low. Therefore, people feel more comfortable getting a procedure done for their aesthetic enhancement. Hence, increased demand for minimally invasive and non-invasive procedures is expected to act as a driver for the market.

Restraint

  • High Cost of Procedures

Modern technology based fat reduction devices help tone and tighten various body parts by reducing fat using technologically advanced modalities such as ultrasound based, lased assisted, or radiofrequency-assisted fat reduction devices. The cost of fat reduction varies significantly from place to place or region to region. The key factors which determine the cost of fat reduction include factors like the medical institution or clinic finalized for the procedure, treatment area, affected area, duration of the stay of the patient, and the complexity of surgery among more. The high cost of the procedure is due to the various checkpoints of the surgery along with the use of high-tech modalities to perform such procedures. As the cost of technologically advanced fat reduction devices is high, the procedure cost proportionally gets escalated, due to which the high cost of the procedure is expected to hamper the demand of the market.

North America Fat Reduction Market

Opportunity

  • Customized Treatment Plans and Integration with Other Aesthetic Procedures

Customized treatment plans and integrating fat reduction procedures with other aesthetic treatments, companies in the North America fat reduction market can provide tailored solutions and enhance the overall treatment experience for their customers. These strategies not only optimize results but also demonstrate a commitment to meeting individual needs and preferences, driving customer satisfaction and loyalty. Therefore customized treatment plans and integration with other aesthetic procedures is expected to create an opportunity for the growth of the market.

Challenge

  • Long-Term Efficacy and Sustainability

Treatment outcomes can be influenced by elements like metabolism, genetics, and lifestyle factors. While some people might have more dramatic and long-lasting benefits, others might need more sessions or extra treatments to get the results they want. Maintaining long-term effectiveness also presents a problem when dealing with persistent fat deposits. Treatments to reduce body fat may be less effective on certain body parts, such as the lower abdomen or love handles.

Long-term efficacy and sustainability is a significant challenge in the North America fat reduction market and is expected to act as a challenge to the growth of the market.

Recent Developments

  • In October 2023, MOLLER Medical is going to organize an event named SOFCEP Congress 2023 from 1 June to 3rd June 2023. This event is themed on aesthetic medicine and the complementarity between aesthetic medicine gestures and interventions. This would help the company to reach a bigger customer base.
  • In August 2023, Implantech is going to organize the event at the Second Multispecialty Aesthetics Conference at the Marriot Marquis Hotel in San Diego, U.S. This conference would help the company in showcasing its innovation in the field of implants.
  • In May 2023, Hironic Co., Ltd. announced that it had won the grand prize in the beauty and medical device category at the Money Today '2023 Consumer Satisfaction Awards' held at the Korea Press Center in Jung-gu, Seoul on the 27. This helps the organization in developing brand image among others.
  • In January 2023, Fotona announced that it showcased its aesthetics product portfolio at the IMCAS congress. It stated that its aesthetic portfolio, the SP Dynamis Nx Line laser system with built-in CoolMist skin cooling and optional Dynamic Vacuum Technology, as well other Fotona products and applications, such as AvalancheLase, TimeWalker Fotona4D were showcased which would help the company in reaching the higher customer base.
  • In June 2019, Cutera launched its new product named truSculpt Flex for the muscle-sculpting market. This new product launched by the company increases its product portfolio in the medical aesthetic segment leading to increased demand for its product in the market.

North America Fat Reduction Market Scope

North America fat reduction market is segmented into six notable segments such as type, application, gender, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Type

  • Surgical Fat Reduction
  • Non-Invasive Fat Reduction
  • Minimally Invasive

Based on type, North America fat reduction market is segmented into surgical fat reduction, non-invasive fat reduction, and minimally invasive.

Application

  • Abdominal Fat
  • Thighs Fat
  • Buttock Fat
  • Upper-Arm Fat
  • Facial Fat-Deposits
  • Knee Fat

Based on application, North America fat reduction market is segmented into abdominal fat, thighs fat, buttock fat, upper-arm fat, facial fat-deposits, and knee fat.

Gender

  • Female
  • Male

Based on gender, North America fat reduction market is segmented into male and female.

Age Group

  • Adult
  • Geriatric
  • Child

Based on age group, North America fat reduction market is segmented into adult, geriatric, and child.

End User

  • Hospitals
  • Multi-Specialty Clinics
  • Dermatology Centers
  • Medical Spas and Beauty Centers
  • Others

Based on end user, North America fat reduction market is segmented into hospitals, multi-specialty clinics, dermatology centers, medical spas, and beauty centers.

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Third Party Distributors
  • Others

Based on the distribution channel, North America fat reduction market is segmented into direct tenders and retail sales, third party distributors, and others.

North America Fat Reduction Market

North America Fat Reduction Market Regional Analysis/Insights

North America fat reduction market is categorized into six notable segments such as type, application, gender, age group, end user, and distribution channel.

The countries covered in this market report U.S., Canada, Mexico, Costa Rica, Dominican Republic, Panama, El Salvador, Guatemala, Honduras, and Nicaragua.

U.S. is expected to dominate the North America fat reduction market due to the presence of key market players in the largest consumer market with a high GDP.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and North America Fat Reduction Market Share Analysis

North America fat reduction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the North America fat reduction market.

Some of the key players operating in the North America fat reduction market are Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical (Subsidiary of Bausch & Lomb Incorporated), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, , Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona, and Implantech, among others.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 BRAND ANALYSIS

4.3.1 KYBELLA

5 INDUSTRY INSIGHTS:

6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS

6.1 U.S.

6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE:

6.1.2 POST-MARKETING SURVEILLANCE:

6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES:

6.2 CANADA

6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE

6.2.2 LICENSING AND REGISTRATION

6.2.3 POST EXPIRY OF PATENT REGIME

6.2.4 POST-MARKETING SURVEILLANCE

6.3 MEXICO

6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE

6.3.2 REGULATORY APPROVAL AGENCIES

6.3.3 LICENSING AND REGISTRATION

6.3.4 POST-MARKETING SURVEILLANCE

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES

7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS

7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS

7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES

7.2 RESTRAINTS

7.2.1 HIGH COST OF PROCEDURES

7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES

7.2.3 PRODUCT RECALL

7.3 OPPORTUNITIES

7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES

7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS

7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES

7.4 CHALLENGES

7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY

7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE

8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE

8.1 OVERVIEW

8.2 SURGICAL FAT REDUCTION

8.2.1 LIPOSUCTION

8.2.1.1 BY TYPE

8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION

8.2.1.1.2 LASER-ASSISTED LIPOSUCTION

8.2.1.1.3 TUMESCENT LIPOSUCTION

8.2.1.1.4 SUPER-WET TECHNIQUE

8.2.1.2 BY APPLICATION

8.2.1.2.1 ABDOMINAL FAT

8.2.1.2.2 THIGHS FAT

8.2.1.2.3 BUTTOCK FAT

8.2.1.2.4 UPPER-ARM FAT

8.2.1.2.5 FACIAL FAT-DEPOSITS

8.2.1.2.5.1 SUBMENTAL AREAS

8.2.1.2.5.2 MALAR

8.2.1.2.5.3 MANDIBULAR

8.2.1.2.6 KNEE FAT

8.2.2 SURGICAL REJUVENATION

8.2.2.1 FACE LIFT

8.2.2.2 NECK LIFT

8.2.3 CHIN IMPLANT

8.2.3.1 SILICONE CHIN IMPLANTS

8.2.3.2 OTHERS

8.2.4 PORUS IMPLANTS

8.2.4.1 TEFLON

8.2.4.2 GORE-TEX

8.2.4.3 MEDPORE IMPLANTS

8.3 NON-INVASIVE FAT REDUCTION

8.3.1 CRYOLIPOLYSIS

8.3.1.1 COOL SCULPTING

8.3.1.2 COOL SCULPTING ELITE

8.3.1.3 COOL TONE

8.3.1.4 OTHERS

8.3.1.4.1 ABDOMINAL FAT

8.3.1.4.2 THIGHS FAT

8.3.1.4.3 BUTTOCK FAT

8.3.1.4.4 UPPER-ARM FAT

8.3.1.4.5 FACIAL FAT-DEPOSITS

8.3.1.4.6 KNEE FAT

8.3.2 ULTRASOUND

8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION

8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION

8.3.2.2.1 ABDOMINAL FAT

8.3.2.2.2 THIGHS FAT

8.3.2.2.3 BUTTOCK FAT

8.3.2.2.4 UPPER-ARM FAT

8.3.2.2.5 FACIAL FAT-DEPOSITS

8.3.2.2.6 KNEE FAT

8.3.3 RADIOFREQUENCY

8.3.3.1 ABDOMINAL FAT

8.3.3.2 THIGHS FAT

8.3.3.3 BUTTOCK FAT

8.3.3.4 UPPER-ARM FAT

8.3.3.5 FACIAL FAT-DEPOSITS

8.3.3.6 KNEE FAT

8.3.4 LOW LEVEL LASER THERAPY

8.3.4.1 ABDOMINAL FAT

8.3.4.2 THIGHS FAT

8.3.4.3 BUTTOCK FAT

8.3.4.4 UPPER-ARM FAT

8.3.4.5 FACIAL FAT-DEPOSITS

8.3.4.6 KNEE FAT

8.3.5 OTHERS

8.4 MINIMALLY INVASIVE

8.4.1 INJECTION LIPOLYSIS

8.4.1.1 DEOXYCHOLIC ACID INJECTIONS

8.4.1.1.1 KYBELLA/BELKYRA

8.4.1.1.1.1 FACIAL FAT-DEPOSITS

8.4.1.1.1.2 UPPER-ARM FAT

8.4.1.1.1.3 ABDOMINAL FAT

8.4.1.1.1.4 THIGHS FAT

8.4.1.1.1.5 KNEE FAT

8.4.1.1.1.6 BUTTOCK FAT

8.4.1.2 PHOSPHATIDYLCHOLINE

8.4.1.2.1 FACIAL FAT-DEPOSITS

8.4.1.2.2 UPPER-ARM FAT

8.4.1.2.3 ABDOMINAL FAT

8.4.1.2.4 THIGHS FAT

8.4.1.2.5 KNEE FAT

8.4.1.2.6 BUTTOCK FAT

8.4.2 OTHERS

9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 ABDOMINAL FAT

9.3 THIGHS FAT

9.4 BUTTOCK FAT

9.5 UPPER-ARM FAT

9.6 FACIAL FAT-DEPOSITS

9.6.1 SUBMENTAL AREAS

9.6.2 MANDIBULAR

9.6.3 MALAR

9.7 KNEE FAT

10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER

10.1 OVERVIEW

10.2 FEMALE

10.3 MALE

11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP

11.1 OVERVIEW

11.2 ADULT

11.3 GERIATRIC

11.4 CHILD

12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 BY TYPE

12.2.1.1 PRIVATE

12.2.1.2 PUBLIC

12.2.2 BY CATEGORY

12.2.2.1 TIER 1

12.2.2.2 TIER 2

12.2.2.3 TIER 3

12.3 MULTISPECIALTY CLINICS

12.4 DERMATOLOGY CENTERS

12.5 MEDICAL SPAS AND BEAUTY CENTERS

12.6 OTHERS

13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDERS

13.3 RETAIL SALES

13.4 THIRD PARTY DISTRIBUTORS

13.5 OTHERS

14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY

14.1 NORTH AMERICA

14.1.1 U.S.

14.1.2 CANADA

14.1.3 MEXICO

14.1.4 COSTA RICA

14.1.5 DOMINICAN REPUBLIC

14.1.6 PANAMA

14.1.7 EL SALVADOR

14.1.8 GUATEMALA

14.1.9 HONDURAS

14.1.10 NICARAGUA

15 COMPANY SHARE ANALYSIS: NORTH AMERICA

16 SWOT ANALYSIS

17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS

17.1 ABBVIE INC.

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENTS

17.2 CYNOSURE

17.2.1 COMPANY SNAPSHOT

17.2.2 PRODUCT PORTFOLIO

17.2.3 RECENT DEVELOPMENTS

17.3 ALMA LASERS

17.3.1 COMPANY SNAPSHOT

17.3.2 PRODUCT PORTFOLIO

17.3.3 RECENT DEVELOPMENT

17.4 CANDELA CORPORATION

17.4.1 COMPANY SNAPSHOT

17.4.2 PRODUCT PORTFOLIO

17.4.3 RECENT DEVELOPMENT

17.5 MERZ NORTH AMERICA, INC.

17.5.1 COMPANY SNAPSHOT

17.5.2 PRODUCT PORTFOLIO

17.5.3 RECENT DEVELOPMENTS

17.6 BLACK & BLACK SURGICAL

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 BTL GROUP OF COMPANIES

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENTS

17.8 BAUSCH HEALTH COMPANIES INC.

17.8.1 COMPANY SNAPSHOT

17.8.2 REVENUE ANALYSIS

17.8.3 PRODUCT PORTFOLIO

17.8.4 RECENT DEVELOPMENT

17.9 CUTERA

17.9.1 COMPANY SNAPSHOT

17.9.2 REVENUE ANALYSIS

17.9.3 PRODUCT PORTFOLIO

17.9.4 RECENT DEVELOPMENT

17.1 ERCHONIA CORPORATION

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 FOTONA

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 GENESIS BIOSYSTEMS, INC.

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

17.13 HIRONIC CO., LTD.

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 IMPLANTECH

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENTS

17.15 LEADERMA INC.

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENT

17.16 LYNTON LASERS LTD

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENT

17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.)

17.17.1 COMPANY SNAPSHOT

17.17.2 REVENUE ANALYSIS

17.17.3 PRODUCT PORTFOLIO

17.17.4 RECENT DEVELOPMENT

17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC.

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENT

17.19 MOLLER MEDICAL

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENT

17.2 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.)

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

17.21 SILIMED

17.21.1 COMPANY SNAPSHOT

17.21.2 PRODUCT PORTFOLIO

17.21.3 RECENT DEVELOPMENTS

17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS

17.22.1 COMPANY SNAPSHOT

17.22.2 PRODUCT PORTFOLIO

17.22.3 RECENT DEVELOPMENT

17.23 VENUS CONCEPT

17.23.1 COMPANY SNAPSHOT

17.23.2 REVENUE ANALYSIS

17.23.3 PRODUCT PORTFOLIO

17.23.4 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

List of Table

TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.

TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.

TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)

TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 203 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 204 COSTA RICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 205 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 206 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 207 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 208 COSTA RICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 209 COSTA RICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 210 COSTA RICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 211 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 212 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 213 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 214 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 215 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 216 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 217 COSTA RICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 218 COSTA RICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 219 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 220 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 221 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 222 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 223 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 224 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 225 COSTA RICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 226 COSTA RICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 227 COSTA RICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 228 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 229 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 230 COSTA RICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 231 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 232 DOMINICAN REPUBLIC SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 233 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 234 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 235 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 236 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 237 DOMINICAN REPUBLIC FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 238 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 239 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 240 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 241 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 242 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 243 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 244 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 245 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 246 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 247 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 248 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 249 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 250 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 251 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 252 DOMINICAN REPUBLIC CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 253 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 254 DOMINICAN REPUBLICULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 255 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 256 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 257 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 258 DOMINICAN REPUBLIC RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 259 DOMINICAN REPUBLIC LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 260 DOMINICAN REPUBLIC MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 261 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 262 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 263 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 264 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 265 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 266 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 267 DOMINICAN REPUBLIC KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 268 DOMINICAN REPUBLIC PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 269 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 270 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 271 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 272 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 273 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 274 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 275 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 276 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 277 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 278 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 279 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 280 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 281 PANAMA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 282 PANAMA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 283 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 284 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 285 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 286 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 287 PANAMA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 288 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 289 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 290 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 291 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 292 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 293 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 294 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 295 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 296 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 297 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 298 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 299 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 300 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 301 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 302 PANAMA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 303 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 304 PANAMAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 305 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 306 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 307 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 308 PANAMA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 309 PANAMA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 310 PANAMA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 311 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 312 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 313 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 314 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 315 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 316 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 317 PANAMA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 318 PANAMA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 319 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 320 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 321 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 322 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 323 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 324 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 325 PANAMA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 326 PANAMA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 327 PANAMA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 328 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 329 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 330 PANAMA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 331 EL SALVADOR FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 332 EL SALVADOR SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 333 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 334 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 335 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 336 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 337 EL SALVADOR FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 338 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 339 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 340 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 341 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 342 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 343 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 344 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 345 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 346 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 347 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 348 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 349 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 350 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 351 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 352 EL SALVADOR CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 353 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 354 EL SALVADORULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 355 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 356 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 357 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 358 EL SALVADOR RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 359 EL SALVADOR LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 360 EL SALVADOR MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 361 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 362 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 363 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 364 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 365 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 366 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 367 EL SALVADOR KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 368 EL SALVADOR PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 369 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 370 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 371 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 372 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 373 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 374 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 375 EL SALVADOR FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 376 EL SALVADOR FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 377 EL SALVADOR FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 378 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 379 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 380 EL SALVADOR FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 381 GUATEMALA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 382 GUATEMALA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 383 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 384 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 385 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 386 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 387 GUATEMALA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 388 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 389 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 390 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 391 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 392 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 393 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 394 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 395 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 396 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 397 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 398 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 399 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 400 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 401 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 402 GUATEMALA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 403 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 404 GUATEMALAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 405 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 406 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 407 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 408 GUATEMALA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 409 GUATEMALA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 410 GUATEMALA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 411 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 412 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 413 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 414 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 415 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 416 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 417 GUATEMALA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 418 GUATEMALA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 419 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 420 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 421 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 422 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 423 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 424 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 425 GUATEMALA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 426 GUATEMALA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 427 GUATEMALA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 428 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 429 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 430 GUATEMALA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 431 HONDURAS FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 432 HONDURAS SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 433 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 434 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 435 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 436 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 437 HONDURAS FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 438 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 439 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 440 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 441 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 442 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 443 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 444 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 445 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 446 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 447 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 448 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 449 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 450 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 451 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 452 HONDURAS CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 453 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 454 HONDURASULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 455 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 456 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 457 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 458 HONDURAS RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 459 HONDURAS LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 460 HONDURAS MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 461 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 462 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 463 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 464 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 465 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 466 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 467 HONDURAS KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 468 HONDURAS PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 469 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 470 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 471 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 472 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 473 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 474 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 475 HONDURAS FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 476 HONDURAS FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 477 HONDURAS FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 478 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 479 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 480 HONDURAS FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 481 NICARAGUA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 482 NICARAGUA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 483 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 484 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 485 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 486 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 487 NICARAGUA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 488 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 489 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 490 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 491 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 492 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 493 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 494 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 495 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 496 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 497 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 498 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 499 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 500 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 501 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 502 NICARAGUA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 503 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 504 NICARAGUAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 505 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 506 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 507 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 508 NICARAGUA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 509 NICARAGUA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 510 NICARAGUA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 511 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 512 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 513 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 514 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 515 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 516 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 517 NICARAGUA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 518 NICARAGUA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 519 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 520 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 521 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 522 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 523 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 524 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 525 NICARAGUA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 526 NICARAGUA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 527 NICARAGUA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 528 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 529 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 530 NICARAGUA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

List of Figure

FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING

FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION

FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033

FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET

FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022

FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION)

FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033)

FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022

FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION)

FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033)

FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022

FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION)

FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033)

FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE

FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022

FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION)

FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033)

FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022

FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION)

FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033)

FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION)

FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033)

FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022)

FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022)

FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033)

FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033)

FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033)

FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

North America Fat Reduction Market will be worth USD 11,773.56 million by 2033.
North America Fat Reduction Market growth rate is 9.9% during the forecast period.
The use of minimally invasive and non–invasive procedures has been shifted as compared to traditional methods for fat reduction techniques including laser and other energy-based devices is the growth drivers of the North America Fat Reduction Market.
Type, application, gender, age group, end user, and distribution channel are the factors on which the North America Fat Reduction Market research is based.
MOLLER Medical is going to organize an event named SOFCEP Congress 2023 from 1 June to 3rd June 2023. This event is themed on aesthetic medicine and the complementarity between aesthetic medicine gestures and interventions and Implantech is going to organize the event at the Second Multispecialty Aesthetics Conference at the Marriot Marquis Hotel in San Diego, U.S are the latest developments in the North America Fat Reduction Market.